BCTX
Briacell Therapeutics CorpNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$25.30M
P/E Ratio
—
EPS
$-14.42
Beta
1.63
52W High
$36.90
52W Low
$2.98
50-Day MA
$4.10
200-Day MA
$7.11
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Briacell Therapeutics Corp
BriaCell Therapeutics Corp. The company is headquartered in West Vancouver, Canada.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-30.63M |
| Operating Margin | 0.00% |
| Return on Equity | -179.20% |
| Return on Assets | -89.40% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $4.26 |
| Price-to-Book | 0.82 |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | -1.38 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $7.25M |
| Float | $6.41M |
| % Insiders | 0.61% |
| % Institutions | 6.35% |
Historical Volatility
HV 10-Day
178.36%
HV 20-Day
126.68%
HV 30-Day
110.74%
HV 60-Day
93.15%
HV Rank
—
Volatility is currently expanding
More HEALTHCARE Stocks
Data last updated: 5/25/2026